• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIU Congyan, WANG Wei, ZHOU Jianping, DING Yang, ZHOU Xin, WANG Zhaoxian. Preparation and evaluation of gambogic acid-loaded reconstituted high density lipoprotein nanoparticles[J]. Journal of China Pharmaceutical University, 2013, 44(4): 311-315. DOI: 10.11665/j.issn.1000-5048.20130405
Citation: LIU Congyan, WANG Wei, ZHOU Jianping, DING Yang, ZHOU Xin, WANG Zhaoxian. Preparation and evaluation of gambogic acid-loaded reconstituted high density lipoprotein nanoparticles[J]. Journal of China Pharmaceutical University, 2013, 44(4): 311-315. DOI: 10.11665/j.issn.1000-5048.20130405

Preparation and evaluation of gambogic acid-loaded reconstituted high density lipoprotein nanoparticles

More Information
  • Gambogic acid(GA)-loaded reconstituted high-density lipoprotein nanoparticles(GA-rHDL-NPs)were prepared by sodium cholate method. The physicochemical properties such as morphology, particle size, Zeta potential, entrapment efficiency and drug-loading capability were evaluated. Dialysis method was employed to investigate in vitro release of GA-rHDL-NPs. In addition, the cellular uptake experiments were performed to evaluate the tumor cellular targeting ability of GA-rHDL-NPs, and safety evaluation following the intravenous injection of GA-rHDL-NPs was carried out using hemolysis testing and irritation testing upon rabbit ear vein. It was found that the well-formulated GA-rHDL-NPs displayed regular spherical shape with particle size of(113. 53±2. 50)nm, Zeta potential of -(29. 48±0. 05)mV, entrapment efficiency of(95. 30±0. 37)% and drug-loading of(8. 51±0. 95)%. The GA-rHDL-NPs solution was found to be stable after one-month storage at 4 °C. In vitro 24-h and 72-h accumulative releases of GA from GA-rHDL-NPs were approximately 24. 3% and 73. 6%, respectively. It revealed that there was much more uptake of GA-rHDL-NPs by HepG2 cells than by L02 cells. GA-rHDL-NPs also exhibited less local venous irritation and hemolysis than did the unencapsulated drug group. Therefore, the GA-rHDL-NPs possessed accepted entrapment efficiency, stability, sustained-release, dispersion and safety properties, and tumor cell uptake, which might be suitable for iv injection and cancer therapy.
  • Related Articles

    [1]QIAN Qianqian, LI Guozhi, TIAN Hong, GAO Xiangdong. Design, preparation, and antitumor activity of fusion protein vaccine based on tumor antigen PBK[J]. Journal of China Pharmaceutical University, 2024, 55(5): 657-665. DOI: 10.11665/j.issn.1000-5048.2024030801
    [2]ZHOU Hongyou, GAO Xiangdong, YAO Wenbing, TIAN Hong. Screening of adjuvant for PD-L1 vaccine based on nitrated T cell epitope[J]. Journal of China Pharmaceutical University, 2024, 55(3): 397-403. DOI: 10.11665/j.issn.1000-5048.2023032801
    [3]LI Mengyuan, JIANG Xiaomeng, SUN Qinyi, GUO Wei. Research progress of CAR-T immunotherapy in solid tumors combined with new strategies[J]. Journal of China Pharmaceutical University, 2023, 54(4): 443-449. DOI: 10.11665/j.issn.1000-5048.2023030101
    [4]SHAO Shishuai, DUAN Shukang, TIAN Hong, YAO Wenbing, GAO Xiangdong. Design and antitumor activity of programmed cell death ligand 1 epitope peptide vaccine[J]. Journal of China Pharmaceutical University, 2023, 54(2): 245-254. DOI: 10.11665/j.issn.1000-5048.2023022803
    [5]WANG Zhenghao, GAO Yafeng, ZHANG Lianjun, LIU Chang. Research progress of T cell anti-tumor function regulated by endoplasmic reticulum stress[J]. Journal of China Pharmaceutical University, 2022, 53(5): 518-524. DOI: 10.11665/j.issn.1000-5048.20220502
    [6]YAO Zheng, LI Zihan, GAO Liming, HU Xing, CHEN Yan, PAN Wenqi, LI Qian. Advances of research on CAR-T cell immunotherapy for solid tumors[J]. Journal of China Pharmaceutical University, 2021, 52(4): 496-504. DOI: 10.11665/j.issn.1000-5048.20210413
    [7]XIA Xuefei, ZHANG Li, LUO Jianhua, YAO Wenbing, GAO Xiangdong, TIAN Hong. Design and antitumor activity of immune checkpoint B7-H3 epitope vaccine[J]. Journal of China Pharmaceutical University, 2021, 52(4): 472-479. DOI: 10.11665/j.issn.1000-5048.20210410
    [8]CHEN Hongmei, KANG Yanliang, LIU Li, YAO Wenbing, TIAN Hong. Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets[J]. Journal of China Pharmaceutical University, 2020, 51(3): 349-356. DOI: 10.11665/j.issn.1000-5048.20200313
    [9]JIANG Liangliang, JIANG Tao, LUO Jianhua, YAO Wenbing, TIAN Hong. A novel human immune system mice model for assessing the immunogenicity of cancer vaccines[J]. Journal of China Pharmaceutical University, 2019, 50(6): 734-742. DOI: 10.11665/j.issn.1000-5048.20190615
    [10]SUN Zhan-yi, CAI Hui, HUANG Zhi-hua, SHI Lei, CHEN Yong-xiang, LI Yan-mei. Advances of glycopeptide-associated tumor vaccines[J]. Journal of China Pharmaceutical University, 2012, 43(2): 97-106.

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return